Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/08/2012CN102626385A Method for adding antibiotics into poultry oil emulsion inactivated vaccine
08/08/2012CN101934076B Bivalent marking live attenuated vaccine of non-propagation genetic engineering for resisting classical swine fever and Japanese encephalitis and application
08/08/2012CN101933903B Oil emulsion vaccine and preparation method thereof
08/08/2012CN101920009B Vaccine for preventing and curing tumor
08/08/2012CN101724010B Preparation method and application of tumor tissue complete antigen
08/08/2012CN101688200B Sequence based engineering and optimization of single chain antibodies
08/08/2012CN101611055B Human antibodies to human DELTA like ligand 4
08/08/2012CN101454345B High affinity antibodies to human il-6 receptor
08/08/2012CN101208102B Immunogenic composition
08/08/2012CN101112618B 疫苗组合物 Vaccine compositions
08/08/2012CN101020055B SARS vaccine based on replicative vaccinia virus vector
08/07/2012USRE43568 Anti-P-selectin antibodies
08/07/2012US8236931 Prevention of aggregation of immunoglobulin light or heavy chains
08/07/2012US8236774 Human telomerase catalytic subunit
08/07/2012US8236771 Vectors and methods for long-term immune evasion to prolong transplant viability
08/07/2012US8236765 Ganglioside epitopes for treating guillain-barre syndrome
08/07/2012US8236751 Methods of increasing muscle mass using follistatin-like related gene (FLRG)
08/07/2012US8236562 Method for producing ready to use, antigen-loaded or unloaded, cryoconserved mature dendritic cells
08/07/2012US8236560 Modified Vaccinia Ankara virus variant and cultivation method
08/07/2012US8236558 Bovine immunodeficiency virus (BIV) based vectors
08/07/2012US8236522 Bacterial extract for digestive or urinary tract disorders and process for its preparation
08/07/2012US8236510 Protein showing enhanced expression in cancer cells
08/07/2012US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use
08/07/2012US8236494 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
08/07/2012US8236487 Tumor specific oligosaccharide sequences and use thereof
08/07/2012US8236355 COX-2 inhibitor
08/07/2012US8236327 Modified flagellin improved toll-like receptor 5 stimulating activity
08/07/2012US8236326 Klebsiella antigens
08/07/2012US8236325 S. epidermidis antigens
08/07/2012US8236324 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
08/07/2012US8236321 Chemically programmable immunity
08/07/2012US8236320 Compositions and methods for using CA9 protein to stimulate an immune response
08/07/2012US8236319 Cross-linkers and their uses
08/07/2012US8236318 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
08/07/2012US8236317 Methods of treating with anti-factor D antibodies
08/07/2012US8236316 Anti-factor XI monoclonal antibodies and methods of use thereof
08/07/2012US8236315 Humanized antibodies specific for von Willebrand factor
08/07/2012US8236314 Agonist antibody to human thrombopoietin receptor
08/07/2012US8236313 Prevention of tissue ischemia, related methods and compositions
08/07/2012US8236312 VEGF-specific human antibody
08/07/2012US8236311 Antibodies against clostridium difficile toxins and uses thereof
08/07/2012US8236310 Antibodies and related molecules that bind to 161P2F10B proteins
08/07/2012US8236309 Use of bispecific antibodies to regulate immune responses
08/07/2012US8236308 Composition comprising cross-species-specific antibodies and uses thereof
08/07/2012US8236307 Humanized anti-FGF19 antagonists and methods using same
08/07/2012US8236306 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
08/07/2012US8236305 Antibodies that bind PAR-2
08/07/2012US8236304 Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate CD4+ and CD8+ T cell immunity
08/07/2012US8236301 Lumican proteoglycan in the diagnosis and treatment of atherosclerosis
08/07/2012US8236298 Picornavirus and Coxsackie virus; oncolysis; ex vivo purging of malignant cells within auto grafts prior to transplantation
08/07/2012CA2525961C Targeted biocides
08/07/2012CA2457414C Virus coat protein/receptor chimeras and methods of use
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2420226C Methods for treating demyelinating diseases
08/07/2012CA2411927C Immunization of dairy cattle with gapc protein against streptococcus infection
08/07/2012CA2402213C Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
08/07/2012CA2319715C Breast cancer resistance protein (bcrp) and the dna which encodes it
08/07/2012CA2309676C Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
08/07/2012CA2286344C Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/02/2012WO2012103510A2 Advanced prime and boost vacinne
08/02/2012WO2012103472A1 Granularized particular thermostable rotovirus vaccine preparation
08/02/2012WO2012103464A2 Oral thin film vaccine preparation
08/02/2012WO2012103444A2 Immunogenic compositions and reagents for preparing
08/02/2012WO2012103365A1 Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseases
08/02/2012WO2012103361A1 Rsv immunization regimen
08/02/2012WO2012103358A1 Conjugates utilizing platform technology for stimulating immune response
08/02/2012WO2012103341A1 Treatment of advanced solid stage tumors using anti-erbb3 antibodies
08/02/2012WO2012103282A2 Methods and compositions for treating alzheimer's disease
08/02/2012WO2012103165A2 Anti-kit antibodies and uses thereof
08/02/2012WO2012103163A2 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
08/02/2012WO2012103114A2 Therapeutic chimeric ligand binding proteins and methods for their use
08/02/2012WO2012103081A1 Methods and assays for treating filoviridae infections
08/02/2012WO2012103060A1 Method of administration and treatment
08/02/2012WO2012102679A1 Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
08/02/2012WO2012102529A2 Composition for regulating circadian rhythms, composition for diagnosing circadian rhythm disorders and diagnostic kit
08/02/2012WO2012102521A2 Human anti-cd23 fab antibody and a pharmaceutical composition for treating tumours comprising same
08/02/2012WO2012101664A1 Use of at least one p75ntr receptor inhibitor, alone or in association with at least one trka receptor activator, or of at least one trka receptor activator, for the treatment of chronic inflammatory diseases
08/02/2012WO2012101253A1 Pharmaceutical compositions comprising human antibodies to pcsk9
08/02/2012WO2012101251A1 Human antibodies to pcsk9 for use in methods of treatment based on particular dosage regimens
08/02/2012WO2012101125A1 Specific antibodies against human cxcl4 and uses thereof
08/02/2012WO2012101112A1 Cyaa-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses
08/02/2012WO2012100599A1 Use of peroxiredoxin iv in preparing in vitro diagnostic reagents for rheumatoid arthritis
08/02/2012WO2012100598A1 Early-stage rheumatoid arthritis specific antigen peroxiredoxin iv
08/02/2012WO2012100453A1 Complex vaccine adjuvant
08/02/2012WO2012100384A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012WO2012100346A1 Antibodies selective for cells presenting egfr at high density
08/02/2012WO2012100343A1 Engineering of immunoglobulin domains
08/02/2012WO2012100302A1 Combination vaccines
08/02/2012WO2012078813A3 Novel modulators and methods of use
08/02/2012WO2012076985A3 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
08/02/2012WO2012072850A3 Compounds for treating cardiac damage after ischaemia/reperfusion
08/02/2012WO2012061400A3 Method for reduction of free polysaccharide in polysaccharide-protein vaccines reactions using ion-exchange matrices
08/02/2012WO2012058493A3 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
08/02/2012WO2012058363A3 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
08/02/2012WO2012055951A3 Immunogenic composition comprising shigella lipopolysaccharide and outer membrane protein
08/02/2012WO2012054654A3 Anti-folate receptor alpha antibody glycoforms
08/02/2012WO2012054584A3 Peptides for modulating t-cell activity and uses thereof
08/02/2012WO2012051498A3 Antibodies that bind amyloid oligomers
1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 1823